Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms

Mutations in SF3B1 are found in 20% of myelodysplastic syndromes and 5–10% of myeloproliferative neoplasms, where they are considered important for diagnosis and therapy decisions. Sanger sequencing and NGS are the currently available methods to identify SF3B1 mutations, but both are time-consuming...

Descripción completa

Detalles Bibliográficos
Autores principales: Petiti, Jessica, Itri, Federico, Signorino, Elisabetta, Frolli, Antonio, Fava, Carmen, Armenio, Marco, Marini, Silvia, Giugliano, Emilia, Lo Iacono, Marco, Saglio, Giuseppe, Cilloni, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911290/
https://www.ncbi.nlm.nih.gov/pubmed/35268357
http://dx.doi.org/10.3390/jcm11051267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911290/
https://www.ncbi.nlm.nih.gov/pubmed/35268357
http://dx.doi.org/10.3390/jcm11051267

Ejemplares similares